To access this element change to forms mode OFF
Grant Award View - GA217001
High-risk lymphoproliferative malignancies in the era of novel...
GA ID:
GA217001
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$136,151.84
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
High-risk lymphoproliferative malignancies in the era of novel therapies: Infection risk, surveillance and prophylaxis
Purpose:
Opportunistic infection risk in lymphoma patients is incompletely understood, especially amongst heavily pre-treated patients receiving novel cellular therapies. This project will explore infection epidemiology, prediction and prophylaxis strategies amongst lymphoma patients. Retrospective cohort analysis, immune-profiling, multivariate analysis of infection risk and national audit of prophylaxis strategies will be conducted, informing future infection prevention and treatment strategies.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2013970
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA